Difference between revisions of "Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5 (Q9838)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Published In Name String (P102): J. Clin. Oncol., #quickstatements; #temporary_batch_1590006349955)
(‎Created claim: Page(s) (P105): 3529-3534, #quickstatements; #temporary_batch_1590074839150)
 
(2 intermediate revisions by the same user not shown)
Property / Volume
 +
29
Property / Volume: 29 / rank
 +
Normal rank
Property / title
 +
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English)
Property / title: Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English) / rank
 +
Normal rank
Property / Page(s)
 +
3529-3534
Property / Page(s): 3529-3534 / rank
 +
Normal rank

Latest revision as of 15:45, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Fouladi M, et al. J. Clin. Oncol. (2011) cited as Ref 575 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Fouladi M
    0 references
    0 references
    2011
    0 references
    J. Clin. Oncol.
    0 references
    29
    0 references
    Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study (English)
    0 references
    3529-3534
    0 references